CAS NO: | 1353644-70-8 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Theliatinib (Xiliertinib) is a potent, ATP-competitive, orally active and highly selectiveEGFRinhibitor with aKiof 0.05 nM and anIC50of 3 nM. Theliatinib has anIC50of 22 nM forEGFRT790M/L858R mutant. Theliatinib shows >50-fold selectivity forEGFRthan other kinases. Anti-tumor activity[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | Theliatinib significantly inhibits EGFR phosphorylation in A431 cells with an IC50of 7 nM. Theliatinib also inhibits A431, H292 and FaDu cells survival with IC50values of 80 nM, 58 nM and 354 nM, respectively[1]. | ||||||||||||||||
体内研究 (In Vivo) | Theliatinib (2-15 mg/kg; oral administration;daily; for 21 days; NOD-SCID mice; PDECX 1T0950 model) treatment demonstrates tumor regression of 75% at the end of study, and with a dose response[1].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 442.51 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C25H26N6O2 | ||||||||||||||||
CAS 号 | 1353644-70-8 | ||||||||||||||||
中文名称 | 西利替尼 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 5 mg/mL(11.30 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |